These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 7774656)

  • 1. An antisense oligodeoxynucleotide to mu-opioid receptors inhibits mu-opioid receptor agonist-induced analgesia in rats.
    Chen XH; Adams JU; Geller EB; DeRiel JK; Adler MW; Liu-Chen LY
    Eur J Pharmacol; 1995 Feb; 275(1):105-8. PubMed ID: 7774656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebroventricular treatment with an antisense oligodeoxynucleotide to kappa-opioid receptors inhibited kappa-agonist-induced analgesia in rats.
    Adams JU; Chen X; DeRiel JK; Adler MW; Liu-Chen LY
    Brain Res; 1994 Dec; 667(1):129-32. PubMed ID: 7895075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test.
    Chen X; Geller EB; Adler MW
    Eur J Pharmacol; 2007 Feb; 557(1):32-6. PubMed ID: 17173891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense oligodeoxynucleotide to a delta-opioid receptor messenger RNA selectively blocks the antinociception induced by intracerebroventricularly administered delta-, but not mu-, epsilon- or kappa-opioid receptor agonists in the mouse.
    Wang HQ; Kampine JP; Tseng LF
    Neuroscience; 1996 Nov; 75(2):445-52. PubMed ID: 8931008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
    Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
    Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
    Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of U50,488H analgesia by antisense oligodeoxynucleotides to a kappa-opioid receptor.
    Chien CC; Brown G; Pan YX; Pasternak GW
    Eur J Pharmacol; 1994 Mar; 253(3):R7-8. PubMed ID: 8200413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist.
    Pakarinen ED; Woods JH; Moerschbaecher JM
    J Pharmacol Exp Ther; 1995 Feb; 272(2):552-9. PubMed ID: 7853168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute delta- and kappa-opioid agonist pretreatment potentiates opioid antagonist-induced suppression of water consumption.
    White DA; Ballard ME; Harmon AC; Holtzman SG
    Brain Res Bull; 2008 Aug; 76(6):597-604. PubMed ID: 18598850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense oligodeoxynucleotide to a delta-opioid receptor selectively blocks the spinal antinociception induced by delta-, but not mu- or kappa-opioid receptor agonists in the mouse.
    Tseng LF; Collins KA; Kampine JP
    Eur J Pharmacol; 1994 Jun; 258(1-2):R1-3. PubMed ID: 7925585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of spinal delta-opioid receptors in mice selectively enhances the attenuation of delta-opioid receptor-mediated antinociception by antisense oligodeoxynucleotide.
    Narita M; Tseng LF
    Eur J Pharmacol; 1995 Sep; 284(1-2):185-9. PubMed ID: 8549623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective blockade of peripheral delta opioid agonist induced antinociception by intrathecal administration of delta receptor antisense oligodeoxynucleotide.
    Bilsky EJ; Wang T; Lai J; Porreca F
    Neurosci Lett; 1996 Dec; 220(3):155-8. PubMed ID: 8994216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
    Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
    Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
    Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity.
    Gengo PJ; Pettit HO; O'Neill SJ; Wei K; McNutt R; Bishop MJ; Chang KJ
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1221-6. PubMed ID: 14534368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used.
    Adams JU; Tallarida RJ; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1261-7. PubMed ID: 8396630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a mu-antisense oligodeoxynucleotide as a mu opioid receptor noncompetitive antagonist in vivo.
    Chen XH; Liu-Chen LY; Tallarida RJ; Geller EB; de Riel JK; Adler MW
    Neurochem Res; 1996 Nov; 21(11):1363-8. PubMed ID: 8947926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. II. A mixed opioid agonist with potent antinociceptive activity and limited effects on respiratory function.
    Gengo PJ; Pettit HO; O'Neill SJ; Su YF; McNutt R; Chang KJ
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1227-33. PubMed ID: 14534367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.
    da Fonseca Pacheco D; Klein A; de Castro Perez A; da Fonseca Pacheco CM; de Francischi JN; Duarte ID
    Br J Pharmacol; 2008 Jul; 154(5):1143-9. PubMed ID: 18469844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.